Need help? Talk to our expert.
WhatsApp

Carcinoembryonic Antigen CEA Test
₹ 980
Carcinoembryonic Antigen CEA Test
₹ 980
51+ booked in last 3 days

Carcinoembryonic Antigen CEA Test

Also Known As :

Report
Report after 32 hours
Fasting
Fasting no
Sample Type
Sample Type serum
Recommended for
Recommended for Male, Female
CEA (Carcino Embryonic Antigen), Serum
₹ 980

Carcino Embryonic Antigen Test Overview

Carcinoembryonic antigen (CEA) is a glycoprotein normally found in embryonic stage. Its concentration in blood increases in certain tumors i.e., colorectal cancer, medullary thyroid carcinoma, breast, gastrointestinal tract, liver, lung, ovarian, pancreatic  and prostatic cancers.
It is often used for monitoring colorectal & gastrointestinal cancer patients and their response to treatment

An example of a tumor marker used to track cancer is CEA. An embryonic stage glycoprotein called CEA is typically present. In certain tumors, such as colorectal cancer, medullary thyroid carcinoma, breast, gastrointestinal tract, liver, lung, ovarian, pancreatic, and prostatic cancer, its blood concentration rises.

It is frequently used to track patients with gastrointestinal and colorectal cancer, as well as their treatment response.

Reasons for Undergoing the CEA Test 

The CEA test, or carcinoembryonic antigen test, is a crucial diagnostic tool in cancer management. There are several key reasons why individuals may undergo a CEA Blood Test: 

  • Before treatment: To establish a baseline CEA level and guide treatment decisions based on the severity of the cancer  

  • During treatment: To monitor the effectiveness of the ongoing cancer treatment by tracking changes in CEA levels 

  • After treatment: To regularly check for any signs of cancer recurrence, especially in cases of colon and rectal cancer 

  • Prognosis: To estimate the expected outcome of the disease and predict the likelihood of recovery or recurrence  

List of Parameters Considered During the CEA Test 

The CEA Test primarily focuses on measuring the level of carcinoembryonic antigen (CEA) in the blood or other bodily fluids. The main parameter analysed in this test is the CEA level.  

Quantified in nanograms per millilitre (ng/mL), CEA levels indicate the presence of cancer or other conditions.  

  • Normal levels are typically less than 2.5 ng/mL in nonsmokers and up to 5.0 ng/mL in smokers.  

  • Elevated levels may suggest cancer presence, spread, or recurrence, but can also result from non-cancerous conditions such as infections, liver disease, ulcers, breast cysts, lung problems, and inflammatory bowel diseases. 

Home Collection for CEA Test Near You 

Metropolis Healthcare offers a convenient home sample collection service for the CEA test, prioritizing comfort and safety for patients. Our trained phlebotomists will visit your doorstep to collect blood samples, ensuring to follow the highest standards of handling while maintaining testing accuracy.  

This service lets you take the CEA blood test conveniently at home, saving you time and effort. With Metropolis Healthcare, you can trust in timely and reliable results, as we are dedicated to making healthcare more accessible and quality diagnostic solutions directly to your doorstep. 

Frequently asked questions

Find quick answers to the most common questions about health tests, bookings, and reports.

Carcino embryonic antigen test is done to monitor patients of malignancy especially colorectal and gastrointestinal cancer.  
Serial monitoring of CEA is done to compare concentrations before and after treatment and also to establish a possible recurrence. Thus it can help assessing the effectiveness of chemotherapy or radiotherapy
This test is not a effective tool to diagnose cancer

carcino embryonic antigen test measures  CEA a glycoprotein, in blood of the patients. Levels increase in patients with certain type of cancers 

The test analyzes a glycoprotein called CEA in the patients' blood. Patients with certain types of cancer experience higher levels.

Carcino embryonic antigen test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer. 

The test requires a blood sample. A tourniquet (elastic band) is tightly tied to the upper arm. The patient is then asked to make a fist. This facilitates the blood filling of the veins. The skin is cleansed before the needle insertion, and the blood sample is collected using a vacutainer.

The results of carcino embryonic antigen test when done over an interval help monitor condition of the patient and his response to treatment. However, a gross increase of CEA to >20 ng/mL in a patient with compatible symptoms are  suggestive of the presence of cancer. 
CEA levels fall after successful treatment to normal levels in 1-4 months
Levels may increase in certain non-cancerous conditions like smoking, hepatic disease, trauma, ulcerative colitis, pancreatitis, cirrhosis,  COPD, Crohn's disease and hypothyroidism. Though the level in such cases is below 10 ng/ mL 
Patients should do a follow-up testing preferably through the same laboratory as different assays can give different result values on the same sample

CEA results may be elevated due to one or more of the following reasons:

  • Smoking.
  • Liver disease.
  • Trauma.
  • Ulcerative colitis.
  • Pancreatitis.
  • Cirrhosis.
  • COPD.
  • Crohn's disease.

Hypothyroidism

Book a Home Visit Now

Book any blood test or health checkup and get tested at the comfort of your home.

Why Metropolis Healthcare?

Metropolis brings 45 years of diagnostics excellence, rooted in science and trust.

With expertise across routine, specialised and super-specialised diagnostics, Metropolis combines scientific excellence, advanced technology and rigorous quality standards to deliver reliable diagnostic solutions across areas such as oncology, neurology, nephrology, women and child health, molecular diagnostics, genomics and more.

NABL & CAP

Accredited labs

Advanced Labs

210+

Clinical Labs

Trusted by

750+ Towns

Pan India Presence

Scientific Officers

2,000+

Scientific Team Members

Proficiency Testing

4,500+

Test & Profiles

Latest Blogs & News

Stay informed with our expert insights and updates.

About Us

Metropolis Healthcare is one of India’s leading diagnostics companies, with 45 years of experience built on scientific expertise, quality and trust. We serve millions of patients through a growing network supported by advanced laboratory infrastructure, technology and a patient-first approach. Our comprehensive portfolio includes 4,500+ tests and profiles across routine, specialised and super-specialised diagnostics, spanning pathology, molecular diagnostics, genomics, cytogenetics, oncology, neurology, nephrology, women and child health, preventive healthcare and wellness.

With 210+ clinical laboratories and a service network of 5,000+ touchpoints reaching more than 750 towns in India, we are focused on making trusted diagnostic services more accessible while maintaining rigorous quality standards. By combining scientific excellence, advanced technology and human expertise, we deliver accurate, reliable and relevant diagnostic insights that support better-informed healthcare decisions.

To book your home visit call us at 080-4891-1400

Book a Home Visit Now!

080-4891-1400
Proceed